North America Generic Oncology Drug Market

The North America generic oncology drug market is expected to exhibit a double-digit growth during 2020-2025. Generic oncology drug helps in controlling, shrinking and destroying cancer cells that are present in the human body. The drug contains the same active ingredient as of a branded drug for cancer care. A generic oncology drug also accounts for the same quality, performance, intended use, strength, dosage form and route of administration as of branded cancer drug but differs in color or flavor. Other than this, the generic drug yields identical therapeutic effects and efficiently deliver equivalent clinical benefits at lower costs, in comparison with its branded counterpart.

The North America generic oncology drug market is currently being driven by several factors. A rapid increase in the number of smokers, coupled with a rise in sedentary lifestyles, has catalyzed the incidences of cancer cases in the region. On account of this, there has been acceleration in the demand for cost-effective and viable cancer treatments, including generic oncology drugs. Apart from this, rising healthcare investments have resulted in the introduction of several improved and effective generic oncology drugs, thereby positively influencing the market growth in the region. Furthermore, rising technological advancements in the healthcare sector have contributed to early cancer diagnosis, thus propelling the demand for generic oncology drugs at the prevention stage. 

IMARC Group’s latest report provides a deep insight into the North America generic oncology drug market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the North America generic oncology drug market in any manner.

Report Scope:

• North America Generic Oncology Drug Market
   
• Key Regions Analysed
  • United States
  • Canada
     
• Analysis for Each Country
   
• Market by Cancer Type
  • Lungs and Bronchus Cancer
  • Colon and Rectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Others
     
• Market by Drug Type
  • Oral Drugs
  • Injectables
  • Others
     
• Market by Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Value Chain Analysis
• Key Drivers and Challenges
• Porters Five Forces Analysis
• Competitive Landscape
  • Competitive Structure
  • Key Player Profiles

Key Questions Answered in This Report:

• How has the North America generic oncology drug market performed so far and how will it perform in the coming years?
• What are the key regions in the North America generic oncology drug market?
• What is the breakup of the North America generic oncology drug market on the basis of cancer type?
• What is the breakup of the North America generic oncology drug market on the basis of drug type?
• What is the breakup of the North America generic oncology drug market on the basis of distribution channel?
• What are the various stages in the value chain of the North America generic oncology drug industry?
• What are the key driving factors and challenges in the North America generic oncology drug industry?
• What is the structure of the North America generic oncology drug industry and who are the key players?
• What is the degree of competition in the North America generic oncology drug industry?
   

Report Coverage:

• Base Year Considered: 2019
• Historical Data Coverage: 2014-2019
• Market Forecast: 2020-2025
• Currency: US$
• Geography Covered: North America, United States and Canada
• Segments Covered: Cancer Type, Drug Type and Distribution Channel.

Report Customization: Although IMARC has tried to cover everything in the North America generic oncology drug market landscape, we believe that every stakeholder may have their own specific needs. In view of this, we provide up to 20-man hours of free customization for each report.

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Generic Oncology Drug Market
    5.1    Market Performance
    5.2    Market Breakup by Cancer Type
    5.3    Market Breakup by Drug Type
    5.4    Market Breakup by Distribution Channel
    5.5    Market Breakup by Region
    5.6    Market Forecast 
6    North America Generic Oncology Drug Market
    6.1    Market Performance
    6.2    Market Forecast 
7    North America Generic Oncology Drug Market: Breakup by Cancer Type 
    7.1   Lungs and Bronchus Cancer 
    7.2   Colon and Rectal Cancer 
    7.3   Breast Cancer  
    7.4   Prostate Cancer   
    7.5   Others  
8    North America Generic Oncology Drug Market: Breakup by Drug Type
    8.1   Oral Drugs 
    8.2   Injectables
    8.3   Others
9    North America Generic Oncology Drug Market: Breakup by Distribution Channel
    9.1   Retail Pharmacies 
    9.2   Hospital Pharmacies
10    North America Generic Oncology Drug Market: Breakup by Country 
    10.1   United States
     10.1.1    Historical Market Trends
     10.1.2    Market Breakup by Cancer Type
     10.1.3    Market Breakup by Drug Type
     10.1.4    Market Breakup by Distribution Channel
     10.1.5    Market Forecast
    10.2   Canada
     10.2.1    Historical Market Trends
     10.2.2    Market Breakup by Cancer Type
     10.2.3    Market Breakup by Drug Type
     10.2.4    Market Breakup by Distribution Channel
     10.2.5    Market Forecast
11    SWOT Analysis 
    11.1    Overview 
    11.2    Strengths
    11.3    Weaknesses 
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis 
13    Porter’s Five Forces Analysis 
    13.1     Overview
    13.2     Bargaining Power of Buyers
    13.3     Bargaining Power of Suppliers
    13.4     Degree of Rivalry
    13.5     Threat of New Entrants
    13.6     Threat of Substitutes
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players

List of Figures

Figure 1: Global: Generic Oncology Drug Market: Sales Value (in Billion US$), 2014-2019
Figure 2: Global: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2019
Figure 3: Global: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2019
Figure 4: Global: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2019
Figure 5: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2019
Figure 6: Global: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 7: North America: Generic Oncology Drug Market: Sales Value (in Billion US$), 2014-2019
Figure 8: North America: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 9: North America: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2019
Figure 10: North America: Generic Oncology Drug (Lungs and Bronchus Cancer) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 11: North America: Generic Oncology Drug (Lungs and Bronchus Cancer) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 12: North America: Generic Oncology Drug (Colon and Rectal Cancer) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 13: North America: Generic Oncology Drug (Colon and Rectal Cancer) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 14: North America: Generic Oncology Drug (Breast Cancer) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 15: North America: Generic Oncology Drug (Breast Cancer) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 16: North America: Generic Oncology Drug (Prostate Cancer) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 17: North America: Generic Oncology Drug (Prostate Cancer) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 18: North America: Generic Oncology Drug (Other Cancer Types) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 19: North America: Generic Oncology Drug (Other Cancer Types) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 20: North America: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2019
Figure 21: North America: Generic Oncology Drug (Oral Drugs) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 22: North America: Generic Oncology Drug (Oral Drugs) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 23: North America: Generic Oncology Drug (Injectables) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 24: North America: Generic Oncology Drug (Injectables) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 25: North America: Generic Oncology Drug (Other Drug Types) Market: Sales Value (in Billion US$), 2014 & 2019
Figure 26: North America: Generic Oncology Drug (Other Drug Types) Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 27: North America: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2019
Figure 28: North America: Generic Oncology Drug Market: Sales Through Retail Pharmacies (in Billion US$), 2014 & 2019
Figure 29: North America: Generic Oncology Drug Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2020-2025
Figure 30: North America: Generic Oncology Drug Market: Sales Through Online Pharmacies (in Billion US$), 2014 & 2019
Figure 31: North America: Generic Oncology Drug Market Forecast: Sales Through Online Pharmacies (in Billion US$), 2020-2025
Figure 32: North America: Generic Oncology Drug Market: Breakup by Country (in %), 2019
Figure 33: United States: Generic Oncology Drug Market: Sales Value (in Billion US$), 2014-2019
Figure 34: United States: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2019
Figure 35: United States: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2019
Figure 36: United States: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2019
Figure 37: United States: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 38: Canada: Generic Oncology Drug Market: Sales Value (in Billion US$), 2014-2019
Figure 39: Canada: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2019
Figure 40: Canada: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2019
Figure 41: Canada: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2019
Figure 42: Canada: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 43: North America: Generic Oncology Drug Industry: SWOT Analysis
Figure 44: North America: Generic Oncology Drug Industry: Value Chain Analysis
Figure 45: North America: Generic Oncology Drug Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: Generic Oncology Drug Market: Key Industry Highlights, 2019 and 2025
Table 2: North America: Generic Oncology Drug Market Forecast: Breakup by Cancer Type (in Billion US$), 2020-2025
Table 3: North America: Generic Oncology Drug Market Forecast: Breakup by Drug Type (in Billion US$), 2020-2025 
Table 4: North America: Generic Oncology Drug Market Forecast: Breakup by Distribution Channel (in Billion US$), 2020-2025
Table 5: North America: Generic Oncology Drug Market Forecast: Breakup by Country (in Billion US$), 2020-2025
Table 6: North America: Generic Oncology Drug Market: Competitive Structure
Table 7: North America: Generic Oncology Drug Market: Key Players